Resch W - Search Results

1

A multiple-site-specific heteroduplex tracking assay as a tool for the study of viral population dynamics.

Resch W, Parkin N, Stuelke EL, Watkins T, Swanstrom R. Resch W, et al. Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):176-81. doi: 10.1073/pnas.98.1.176. Proc Natl Acad Sci U S A. 2001. PMID: 11120887 Free PMC article.

2

Selection of high-level resistance to human immunodeficiency virus type 1 protease inhibitors.

Watkins T, Resch W, Irlbeck D, Swanstrom R. Watkins T, et al. Among authors: resch w. Antimicrob Agents Chemother. 2003 Feb;47(2):759-69. doi: 10.1128/AAC.47.2.759-769.2003. Antimicrob Agents Chemother. 2003. PMID: 12543689 Free PMC article.

3

Nelfinavir-resistant, amprenavir-hypersusceptible strains of human immunodeficiency virus type 1 carrying an N88S mutation in protease have reduced infectivity, reduced replication capacity, and reduced fitness and process the Gag polyprotein precursor aberrantly.

Resch W, Ziermann R, Parkin N, Gamarnik A, Swanstrom R. Resch W, et al. J Virol. 2002 Sep;76(17):8659-66. doi: 10.1128/jvi.76.17.8659-8666.2002. J Virol. 2002. PMID: 12163585 Free PMC article.

4

Effect of a protease inhibitor-induced genetic bottleneck on human immunodeficiency virus type 1 env gene populations.

Kitrinos KM, Nelson JA, Resch W, Swanstrom R. Kitrinos KM, et al. Among authors: resch w. J Virol. 2005 Aug;79(16):10627-37. doi: 10.1128/JVI.79.16.10627-10637.2005. J Virol. 2005. PMID: 16051855 Free PMC article.

5

Evolution of human immunodeficiency virus type 1 protease genotypes and phenotypes in vivo under selective pressure of the protease inhibitor ritonavir.

Resch W, Parkin N, Watkins T, Harris J, Swanstrom R. Resch W, et al. J Virol. 2005 Aug;79(16):10638-49. doi: 10.1128/JVI.79.16.10638-10649.2005. J Virol. 2005. PMID: 16051856 Free PMC article.

6

Using HIV-1 sequence variability to explore virus biology.

McGrath KM, Hoffman NG, Resch W, Nelson JA, Swanstrom R. McGrath KM, et al. Among authors: resch w. Virus Res. 2001 Aug;76(2):137-60. doi: 10.1016/s0168-1702(01)00271-4. Virus Res. 2001. PMID: 11410314 Review.

7

Improved success of phenotype prediction of the human immunodeficiency virus type 1 from envelope variable loop 3 sequence using neural networks.

Resch W, Hoffman N, Swanstrom R. Resch W, et al. Virology. 2001 Sep 15;288(1):51-62. doi: 10.1006/viro.2001.1087. Virology. 2001. PMID: 11543657 Free article.

8

Vaccinia virus D10 protein has mRNA decapping activity, providing a mechanism for control of host and viral gene expression.

Parrish S, Resch W, Moss B. Parrish S, et al. Among authors: resch w. Proc Natl Acad Sci U S A. 2007 Feb 13;104(7):2139-44. doi: 10.1073/pnas.0611685104. Epub 2007 Feb 5. Proc Natl Acad Sci U S A. 2007. PMID: 17283339 Free PMC article.

9

Vaccinia virus nonstructural protein encoded by the A11R gene is required for formation of the virion membrane.

Resch W, Weisberg AS, Moss B. Resch W, et al. J Virol. 2005 Jun;79(11):6598-609. doi: 10.1128/JVI.79.11.6598-6609.2005. J Virol. 2005. PMID: 15890898 Free PMC article.

10

The conserved poxvirus L3 virion protein is required for transcription of vaccinia virus early genes.

Resch W, Moss B. Resch W, et al. J Virol. 2005 Dec;79(23):14719-29. doi: 10.1128/JVI.79.23.14719-14729.2005. J Virol. 2005. PMID: 16282472 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters